Bionano to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference
01 February 2024 - 12:00AM
Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik
Holmlin, PhD, Bionano’s president and chief executive officer, will
participate in the BTIG Snowbird MedTech, Digital Health, Life
Science & Diagnostic Tools Conference, which will take place
February 13-14, 2024.
Please contact your BTIG representative if you would like to
schedule a virtual or in-person meeting with Bionano during the
conference. For more information about the BTIG Snowbird MedTech,
Digital Health, Life Science & Diagnostic Tools Conference
please refer to the BTIG website.
About Bionano
Bionano is a provider of genome analysis
solutions that can enable researchers and clinicians to reveal
answers to challenging questions in biology and medicine. The
Company’s mission is to transform the way the world sees the genome
through OGM solutions, diagnostic services and software. The
Company offers OGM solutions for applications across basic,
translational and clinical research. Through its Lineagen, Inc.
d/b/a Bionano Laboratories business, the Company also provides
diagnostic testing for patients with clinical presentations
consistent with autism spectrum disorder and other
neurodevelopmental disabilities. The Company also offers an
industry-leading, platform-agnostic software solution, which
integrates next-generation sequencing and microarray data designed
to provide analysis, visualization, interpretation and reporting of
copy number variants, single-nucleotide variants and absence of
heterozygosity across the genome in one consolidated view. The
Company additionally offers nucleic acid extraction and
purification solutions using proprietary isotachophoresis (ITP)
technology. For more information, visit www.bionano.com,
www.bionanolaboratories.com or www.purigenbio.com.
Bionano’s OGM products are for research use only
and not for use in diagnostic procedures.
CONTACTS
Company Contact:Erik Holmlin, CEOBionano
Genomics, Inc.+1 (858) 888-7610eholmlin@bionano.com
Investor Relations:David HolmesGilmartin
Group+1 (858) 888-7625IR@bionano.com
Bionano Genomics (NASDAQ:BNGO)
Historical Stock Chart
From Apr 2024 to May 2024
Bionano Genomics (NASDAQ:BNGO)
Historical Stock Chart
From May 2023 to May 2024